Experience of application 0.1% methylprednisolone aceponatе in a complex therapy chronic dermatoses

Abstract

The review describes the structure and pharmacokinetics of 0.1% methylprednisolone aceponate, world’s data practice, showing high efficiency and safety of this drug in the treatment of chronic dermatoses, presents the results of study the therapeutic efficacy of different medicinal forms.

Keywords

• 0
• 1% метилпреднизолона ацепонат
• хронические воспалительные заболевания кожи
• атопический дерматит
• экзема
• эффективность
• безопасность
• керамиды
• комфодерм
• 0
• 1% methylprednisolone aceponate
• chronic inflammatory disease of the skin
• atopic dermatitis
• eczema
• efficiency
• safety
• komfoderm